LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
MCF7	Imatinib	0.04	uM	LJP6	72	hr	1209	3887	4012	0.9694	0.9648
MCF7	Crizotinib	0.04	uM	LJP5	72	hr	1209	3621	4203	0.8617	0.8409
MCF7	JW-7-24-1	0.04	uM	LJP6	72	hr	1209	2904	4012	0.7236	0.6583
MCF7	Tozasertib	0.04	uM	LJP5	72	hr	1209	1353	4203	0.3225	0.0646
MCF7	CGP60474	0.04	uM	LJP6	72	hr	1209	681	4012	0.1703	-0.2823
MCF7	PD173074	0.04	uM	LJP6	72	hr	1209	4081	4012	1.0185	1.0223
MCF7	HG-6-64-01	0.04	uM	LJP6	72	hr	1209	4320	4012	1.0763	1.0866
MCF7	Neratinib	0.04	uM	LJP5	72	hr	1209	3690	4203	0.8761	0.8552
MCF7	HG-5-113-01	0.04	uM	LJP5	72	hr	1209	3957	4203	0.9412	0.9334
MCF7	Dasatinib	0.04	uM	LJP6	72	hr	1209	1642	4012	0.4094	0.1929
MCF7	NVP-TAE684	0.04	uM	LJP6	72	hr	1209	1984	4012	0.4944	0.3304
MCF7	CGP60474	0.04	uM	LJP5	72	hr	1209	3388	4203	0.8081	0.7768
MCF7	AT-7519	0.04	uM	LJP6	72	hr	1209	1716	4012	0.4263	0.2189
MCF7	HG-5-88-01	0.04	uM	LJP6	72	hr	1209	3074	4012	0.7659	0.7136
MCF7	Seliciclib	0.04	uM	LJP5	72	hr	1209	4445	4203	1.0582	1.0640
MCF7	AZD7762	0.04	uM	LJP6	72	hr	1209	1961	4012	0.4890	0.3221
MCF7	GW843682X	0.04	uM	LJP6	72	hr	1209	2523	4012	0.6295	0.5304
MCF7	AZD8055	0.04	uM	LJP6	72	hr	1209	1199	4012	0.2986	-0.0063
MCF7	Sorafenib	0.04	uM	LJP6	72	hr	1209	3745	4012	0.9334	0.9219
MCF7	CP724714	0.04	uM	LJP5	72	hr	1209	3813	4203	0.9088	0.8972
MCF7	Dasatinib	0.04	uM	LJP5	72	hr	1209	3206	4203	0.7621	0.7182
MCF7	CP466722	0.04	uM	LJP5	72	hr	1209	4412	4203	1.0522	1.0586
MCF7	Alvocidib	0.04	uM	LJP6	72	hr	1209	673	4012	0.1682	-0.2872
MCF7	KIN001-043	0.04	uM	LJP6	72	hr	1209	3628	4012	0.9066	0.8906
MCF7	BMS345541	0.04	uM	LJP6	72	hr	1209	4237	4012	1.0560	1.0640

<
<<
Previous
Page 1 of 166
Next
>>
>
1 to 25 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)